Efficient Particle Analysis eBook
Understanding and controlling subvisible particles is critical to ensuring the safety and efficacy of biologic drug formulations. In Efficient Particle…
Read MoreGEN – An Automated, High-Throughput Approach for Stability Testing in Protein, Cell, and Gene Therapeutics
Product safety and efficacy is an integral part of conversations about the potential of cell and gene therapies, particularly when…
Read MoreHalo University: Intro to BMI 101: How it’s Used in Protein, Cell, and Gene Therapeutics
In this Halo University lesson, learn the fundamentals of Backgrounded Membrane Imaging (BMI) on Aura® systems, and how it is…
Read MoreHalo University: AUR102 Why upgrading to Aura can help with your SVP analysis
The Aura® suite of instruments was released onto the market in 2020. Since then, this platform has seen significant growth in adoption…
Read MoreGEN – Ultra-Low Volume Biophysical Characterization for Viral Vectors and LNPs
Subvisible aggregates are a critical quality attribute (CQA) and a key measure of physical stability for all biologics. Aggregates are…
Read MoreDTR – Complete Aggregate and Particle Characterization of Protein, Gene, and Cell Therapies
In this webinar, our key speaker Dikran Khachadourian, will discuss how Aura® incorporates the techniques of Backgrounded Membrane Imaging (BMI)…
Read MoreComplete Characterization of Subvisible Aggregates and Impurities in Protein, Gene, and Cell Therapies Using Aura+
In all biological products, distinguishing aggregated API from other particle types matters for understanding the root cause of instability. Until…
Read MoreApp Note 22: Detecting Glass Particles – Making the Invisible Visible to Avoid the Leading Cause of Drug Recalls
Please fill out the form to download the app note.
Read MoreIdentification of Stable Cell and Gene Therapeutics and Characterization of Subvisible Aggregates
In all biologics, subvisible aggregates are a critical quality attribute and key indicator of product stability. Here we present the…
Read MoreHalo U: FMM 201 and SMI 301: Subvisible Particle Identification using Side-Illumination and Fluorescence Membrane Microscopy on Protein Therapeutic Formulations
Subvisible particles are a critical quality attribute (CQA) for protein therapeutics that can limit a product’s shelf-life and induce immunogenicity.…
Read More
